Metabolism during ECM Detachment: Achilles Heel of Cancer Cells?

Trends in Cancer

Volumn 3, Issue 7, 2017, Pages 475-481

  Mason, Joshua A ^a   Hagel, Kimberly R ^a   Hawk, Mark A ^a   Schafer, Zachary T ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

anoikis; cell death; metabolism; metastasis; reactive oxygen species

Indexed keywords

REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; GLUCOSE; INTEGRIN; PENTOSE PHOSPHATE;

ACHILLES TENDON; ANOIKIS; APOPTOSIS; CANCER CELL; CELL METABOLISM; CELL VIABILITY; EXTRACELLULAR MATRIX; GLUCOSE METABOLISM; HUMAN; LONG TERM SURVIVAL; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; REVIEW; CELL ADHESION; CELL SURVIVAL; DRUG EFFECT; METABOLISM; NEOPLASM;

ANOIKIS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GLUCOSE; HUMANS; INTEGRINS; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS; PENTOSEPHOSPHATES; REACTIVE OXYGEN SPECIES;

EID: 85019649022     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2017.04.009     Document Type: Review

References (54)

1. Frisch, S.M., Francis, H., Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124 (1994), 619–626.
2. Buchheit, C.L., et al. The regulation of cancer cell death and metabolism by extracellular matrix attachment. Semin. Cell Dev. Biol. 23 (2012), 402–411.
3. Buchheit, C.L., et al. Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression. Nat. Rev. Cancer 14 (2014), 632–641.
4. Rayavarapu, R.R., et al. The role of multicellular aggregation in the survival of ErbB2-positive breast cancer cells during extracellular matrix detachment. J. Biol. Chem. 290 (2015), 8722–8733.
5. Buchheit, C.L., et al. Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration. Cell Death Differ. 22 (2015), 1275–1286.
6. Weigel, K.J., et al. CAF-secreted IGFBPs regulate breast cancer cell anoikis. Mol. Cancer Res. 12 (2014), 855–866.
7. Simpson, C.D., et al. Anoikis resistance and tumor metastasis. Cancer Lett. 272 (2008), 177–185.
8. Overholtzer, M., et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 131 (2007), 966–979.
9. Mailleux, A.A., et al. BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev. Cell 12 (2007), 221–234.
10. Fung, C., et al. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol. Biol. Cell 19 (2008), 797–806.
11. Debnath, J., et al. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111 (2002), 29–40.
12. Schafer, Z.T., et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461:7260 (2009), 109–113.
13. Davison, C.A., et al. Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. Cancer Res. 73 (2013), 3704–3715.
14. Mason, J.A., et al. Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells. Cell Death Differ. 23 (2016), 1271–1282.
15. DeBerardinis, R.J., The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7 (2008), 11–20.
16. Vander Heiden, M.G., DeBerardinis, R.J., Understanding the Intersections between Metabolism and Cancer Biology. Cell 168 (2017), 657–669.
17. Pavlova, N.N., Thompson, C.B., The emerging hallmarks of cancer metabolism. Cell Metab. 23 (2016), 27–47.
18. Locasale, J.W., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43 (2011), 869–874.
19. Fan, J., et al. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510 (2014), 298–302.
20. Grassian, A.R., et al. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev. 25 (2011), 1716–1733.
21. Wellen, K.E., Thompson, C.B., A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13 (2012), 270–276.
22. Christofk, H.R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452 (2008), 230–233.
23. Anastasiou, D., et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334 (2011), 1278–1283.
24. Bensinger, S.J., Christofk, H.R., New aspects of the Warburg effect in cancer cell biology. Semin. Cell Dev. Biol. 23 (2012), 352–361.
25. Hosios, A.M., et al. Lack of evidence for PKM2 protein kinase activity. Mol. Cell 59 (2015), 850–857.
26. Dayton, T.L., et al. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes Dev. 30 (2016), 1020–1033.
27. Park, S.H., et al. SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor growth. Cancer Res. 76 (2016), 3802–3812.
28. Ray, P.D., et al. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24 (2012), 981–990.
29. Christofk, H.R., et al. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452 (2008), 181–186.
30. Possemato, R., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476 (2011), 346–350.
31. Amelio, I., et al. Serine and glycine metabolism in cancer. Trends Biochem. Sci. 39 (2014), 191–198.
32. Hitosugi, T., et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell 22 (2012), 585–600.
33. Lien, E.C., et al. Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer. Nat. Cell Biol. 18 (2016), 572–578.
34. Yun, J., et al. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350 (2015), 1391–1396.
35. Hawk, M.A., et al. Antioxidant activity during tumor progression: a necessity for the survival of cancer cells?. Cancers (Basel), 8, 2016, E92.
36. DeNicola, G.M., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475 (2011), 106–109.
37. Le Gal, K., et al. Antioxidants can increase melanoma metastasis in mice. Sci. Transl. Med., 7, 2015, 308re8.
38. Piskounova, E., et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527 (2015), 186–191.
39. Sayin, V.I., et al. Antioxidants accelerate lung cancer progression in mice. Sci. Transl. Med., 6, 2014, 221ra15.
40. Choo, A.Y., et al. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol. Cell 38 (2010), 487–499.
41. Yang, C., et al. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 69 (2009), 7986–7993.
42. DeBerardinis, R.J., Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 19345–19350.
43. DeBerardinis, R.J., Cheng, T., Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29 (2010), 313–324.
44. Jiang, L., et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532 (2016), 255–258.
45. Mullen, A.R., et al. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. Cell Rep. 7 (2014), 1679–1690.
46. Mullen, A.R., et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481 (2012), 385–388.
47. Yang, C., et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol. Cell 56 (2014), 414–424.
48. Son, J., et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496 (2013), 101–105.
49. Scherz-Shouval, R., Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26 (2007), 1749–1760.
50. Lock, R., et al. Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 4 (2014), 466–479.
51. Lock, R., et al. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell 22 (2011), 165–178.
52. Avivar-Valderas, A., Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene 32 (2013), 4932–4940.
53. Jeon, S.M., et al. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485 (2012), 661–665.
54. White, E., Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12 (2012), 401–410.